Underdiagnosis of familial hypercholesterolaemia: innovation is overdue

Eur Heart J. 2022 Sep 7;43(34):3255-3257. doi: 10.1093/eurheartj/ehab869.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Hyperlipoproteinemia Type II* / diagnosis
  • Hyperlipoproteinemia Type II* / genetics
  • Metagenomics*
  • Young Adult